Allurion Technologies (ALUR) Change in Account Payables (2022 - 2026)
Allurion Technologies (ALUR) posted Change in Account Payables of -$347000.0 for Q1 2026, down 151.56% on a QoQ basis from $673000.0 in Q4 2025, and up 85.6% year-over-year from -$186965.6 in Q1 2025.
Allurion Technologies (ALUR) Change in Account Payables (2022 - 2026) Analysis & Trends
Allurion Technologies' Change in Account Payables history runs 5 years deep, the most recent figure standing at -$347000.0 for Q1 2026.
- Quarterly Change in Account Payables rose 85.6% year-over-year to -$347000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (up 86.31% YoY) and the FY2025 annual result came in at -$3.1 million, up 19.95% from the prior year.
- Change in Account Payables was -$347000.0 for Q1 2026 at Allurion Technologies, down from $673000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $5.4 million in Q1 2023 and bottomed at -$4.1 million in Q2 2024.
- A 5-year average of -$103133.3 and a median of -$333000.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables jumped 335.69% — and 2024, when it plunged 1117.72%.
- Allurion Technologies' Change in Account Payables stood at $269000.0 in 2022, then surged by 335.69% to $1.2 million in 2023, then sank by 385.49% to -$3.3 million in 2024, then surged by 120.11% to $673000.0 in 2025, then tumbled by 151.56% to -$347000.0 in 2026.
- Business Quant data shows ALUR's Change in Account Payables at -$347000.0 in Q1 2026, $673000.0 in Q4 2025, and -$921000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -347,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -347,000.00 |
| Mar 31, 2026 | -347,000.00 |
| Dec 31, 2025 | 673,000.00 |
| Dec 31, 2025 | 673,000.00 |
| Sep 30, 2025 | -921,000.00 |
| Sep 30, 2025 | -921,000.00 |
| Jun 30, 2025 | -484,000.00 |
| Jun 30, 2025 | -484,000.00 |
| Mar 31, 2025 | -2.41 Mn |
| Mar 31, 2025 | -2.41 Mn |
| Dec 31, 2024 | -3.35 Mn |
| Dec 31, 2024 | -3.35 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | -4.06 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2023 | 1.17 Mn |